ICU
SeaStar Medical Holding Corp
NASDAQ · Healthcare · Biotechnology · US
$2.03
+1.25%Research · Aug 25, 2026
CRRT Anticoagulation Adds Nafamostat as Fallback in Draft KDIGO Guidelines
The draft KDIGO acute kidney injury guideline raises regional citrate to 1B and names nafamostat as a fallback, a protocol most US ICUs do not run today.